Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 3
Out of 5,124 analysts
138
Total ratings
64.95%
Success rate
156.82%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Hold | $100 → $105 | $101.59 | +3.36% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $216.61 | +26.96% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $11.26 | -20.07% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $90.61 | +29.12% | 1 | Dec 1, 2025 | |
| DGX Quest Diagnostics | Maintains: Buy | $200 → $215 | $190.71 | +12.74% | 3 | Oct 21, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $381.29 | +0.97% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $129.58 | +19.62% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $84.29 | -5.09% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $29.10 | +51.20% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,373.57 | -19.92% | 8 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $277.20 | +4.62% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $11.42 | +92.64% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $74.81 | +13.62% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $50.95 | +3.96% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $49.24 | -28.92% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $18.61 | +28.96% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.82 | +119.78% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.03 | +47.78% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $203.04 | -30.06% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $101.85 | -68.58% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $119.72 | -3.94% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $5.13 | +289.86% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $542.83 | +19.74% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $17.75 | -49.30% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.88 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.80 | +566.67% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $6.09 | +885.22% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.80 | +379.17% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $189.21 | +106.12% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.71 | +564.21% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $488.15 | -59.03% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $29.10 | -17.53% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $13.76 | +227.03% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $142.18 | -50.77% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $187.49 | -36.00% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.62 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $41.93 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $8.71 | +531.46% | 1 | Jul 19, 2016 |
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $101.59
Upside: +3.36%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $216.61
Upside: +26.96%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $11.26
Upside: -20.07%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $90.61
Upside: +29.12%
Quest Diagnostics
Oct 21, 2025
Maintains: Buy
Price Target: $200 → $215
Current: $190.71
Upside: +12.74%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $381.29
Upside: +0.97%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $129.58
Upside: +19.62%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $84.29
Upside: -5.09%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $29.10
Upside: +51.20%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,373.57
Upside: -19.92%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $277.20
Upside: +4.62%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $11.42
Upside: +92.64%
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $74.81
Upside: +13.62%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $50.95
Upside: +3.96%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $49.24
Upside: -28.92%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $18.61
Upside: +28.96%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.82
Upside: +119.78%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.03
Upside: +47.78%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $203.04
Upside: -30.06%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $101.85
Upside: -68.58%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $119.72
Upside: -3.94%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $5.13
Upside: +289.86%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $542.83
Upside: +19.74%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $17.75
Upside: -49.30%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.88
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.80
Upside: +566.67%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $6.09
Upside: +885.22%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.80
Upside: +379.17%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $189.21
Upside: +106.12%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.71
Upside: +564.21%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $488.15
Upside: -59.03%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $29.10
Upside: -17.53%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $13.76
Upside: +227.03%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $142.18
Upside: -50.77%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $187.49
Upside: -36.00%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.62
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $41.93
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $8.71
Upside: +531.46%